Get started
Author

Anosheh Afghahi

A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genes
2022 · Joshua J. Gruber, Anosheh Afghahi, et al. · Nature Cancer · 129
PDF
Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer
2018 · Anosheh Afghahi, Natasha Purington, et al. · Clinical Cancer Research · 89
PDF
Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance
2017 · Anosheh Afghahi, Kirsten M. Timms, et al. · Clinical Cancer Research · 73
Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement
2013 · S. Dinner, W. Witteles, et al. · Haematologica · 62
PDF
Sexual health after a breast cancer diagnosis in young women: clinical implications for patients and providers
2020 · Sydney Marsh, Virginia F. Borges, et al. · Breast Cancer Research and Treatment · 57
Interventions to Improve Sexual Health in Women Living with and Surviving Cancer: Review and Recommendations
2021 · Jenna Sopfe, Jessica Pettigrew, et al. · Cancers · 49
PDF
Talazoparib beyond BRCA: A phase II trial of talazoparib monotherapy in BRCA1 and BRCA2 wild-type patients with advanced HER2-negative breast cancer or other solid tumors with a mutation in homologous recombination (HR) pathway genes.
2019 · Joshua James Gruber, Anosheh Afghahi, et al. · Journal of Clinical Oncology · 49
Targeted Therapy for Cancer in the Genomic Era
2015 · Anosheh Afghahi, George W. Sledge · The Cancer Journal · 49
Macrophages Promote Circulating Tumor Cell–Mediated Local Recurrence following Radiotherapy in Immunosuppressed Patients
2018 · Marjan Rafat, Todd A. Aguilera, et al. · Cancer Research · 47
Association of increased tumor-infiltrating lymphocytes (TILs) with immunomodulatory (IM) triple-negative breast cancer (TNBC) subtype and response to neoadjuvant platinum-based therapy in PrECOG0105.
2014 · Shaveta Vinayak, Robert James Gray, et al. · Journal of Clinical Oncology · 38
Genetics of triple-negative breast cancer: Implications for patient care
2016 · Anosheh Afghahi, Melinda L. Telli, et al. · Current Problems in Cancer · 36
Abstract PS11-05: Updated data from SERENA-1: A Phase 1 dose escalation and expansion study of the next generation oral SERD AZD9833 as a monotherapy and in combination with palbociclib, in women with ER-positive, HER2-negative advanced breast cancer
2021 · Richard Baird, Mafalda Oliveira, et al. · Cancer Research · 32
The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition
2017 · Anosheh Afghahi, Allison W. Kurian · Current Treatment Options in Oncology · 31
Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice
2024 · Debra L. Richardson, Julia C. F. Quintanilha, et al. · Clinical Cancer Research · 30
No One-Size-Fits-All: Sexual Health Education Preferences in Patients with Breast Cancer
2022 · Victoria Huynh, Sudheer Vemuru, et al. · Annals of Surgical Oncology · 29
PDF
Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer
2015 · Anosheh Afghahi, Erna Forgó, et al. · Breast Cancer Research · 24
PDF
More Than a Frog in the Throat
2012 · Ryan Stevenson, Ronald Witteles, et al. · Archives of Otolaryngology - Head and Neck Surgery · 20
Abstract CT145: Olaparib +/- atezolizumab in patients with BRCA-mutated (BRCAmt) locally advanced unresectable or metastatic (advanced) breast cancer: an open-label, multicenter, randomized phase II trial
2023 · Kristina A. Fanucci, Mary Jo Pilat, et al. · Cancer Research · 19
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2− advanced breast cancer
2023 · Anthony D. Elias, Nicole S. Spoelstra, et al. · npj Breast Cancer · 18
PDF
Characterizing informational needs and information seeking behavior of patients with breast cancer
2023 · Abigail Ludwigson, Victoria Huynh, et al. · The American Journal of Surgery · 17
PDF
Moving Towards Targeted Therapies for Triple-Negative Breast Cancer
2021 · Jodi A. Kagihara, Elena Shagisultanova, et al. · Current Breast Cancer Reports · 16
Lymphopenia after adjuvant radiotherapy (RT) to predict poor survival in triple-negative breast cancer (TNBC).
2015 · Anosheh Afghahi, Maya Mathur, et al. · Journal of Clinical Oncology · 15
Clinical implications of receptor conversions in breast cancer patients who have undergone neoadjuvant chemotherapy
2023 · Sudheer Vemuru, Jin Huang, et al. · Breast Cancer Research and Treatment · 12
PDF
Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study
2019 · Allison H. West, Hayley Knollman, et al. · Cancer Medicine · 11
PDF
Use of Gene Expression Profiling and Chemotherapy in Early-Stage Breast Cancer: A Study of Linked Electronic Medical Records, Cancer Registry Data, and Genomic Data Across Two Health Care Systems
2016 · Anosheh Afghahi, Maya Mathur, et al. · Journal of Oncology Practice · 11
Works count: 87
Citation count: 1,011
H-index: 18
I10-index: 25
Year
Topic
Type